Quick Dispatch:
Your semaglutide prostate cancer Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide prostate cancer Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients ships.
Need Help?
Questions about semaglutide prostate cancer Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide prostate cancer Metabolic Drugs and Prostate Cancer: Analyzing GLP-1 Agonist Use in Patients in your area.
Progress in therapy across the spectrum of advanced prostate cancer
27.95
Neoadjuvant 177Lutetium-PSMA-617 Radioligand Therapy for High-Risk Localized Prostate Cancer: Rationale, Early Clinical Evidence, and Future Directions
25.38
GLP-1 drugs may have a beneficial effect across many types of cancer
25.91
Prostate Cancer Treatment (PDQ®)
22.50
Treatments Expanding for Metastatic Prostate Cancer
26.80
![First-Line [177Lu]Lu-PSMA-617 Therapy Without ADT, Chemotherapy, or Local Therapy for Metastatic Hormone-Sensitive Prostate Cancer](https://jnm.snmjournals.org/content/jnumed/early/2025/09/25/jnumed.125.270704/F1.large.jpg)
First-Line [177Lu]Lu-PSMA-617 Therapy Without ADT, Chemotherapy, or Local Therapy for Metastatic Hormone-Sensitive Prostate Cancer
26.22
Prostate Cancer Treatment (PDQ®)
23.95
